About Gene List

PF3D7_1136300 (TSN)

Genome location: Pf3D7_11_v3:1,421,786..1,426,832(+)

Genome classification: Core

Function and Localization

Product Description: tudor staphylococcal nuclease

SignalP Peptide: N/A

# Transmembrane Domains: 0

EC Numbers: 3.1.31.1 (Micrococcal nuclease)

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005737 cytoplasm
Component GO:0005634 nucleus
Function GO:0003723 RNA binding
Function GO:0005509 calcium ion binding
Function GO:0004518 nuclease activity
Function GO:0005515 protein binding
Process GO:0006401 RNA catabolic process

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite not expressed N/A N/A
Ring expressed 0.66 0.71
Trophozoite expressed 1.40 0.35
Schizont expressed 0.78 0.58
Gametocyte expressed 0.86 0.55

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_1136300

Resistome Missense Mutations: None

Resistome Compounds with Missense Mutations: None

Resistome # Samples with Disruptive Mutations: 0 (0 missense, 0 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Mutable in CDS

MIS: 1 | MFS: -2.071 | #Insertions: 4

PlasmoGEM Phenotype: Dispensable (Pb ortholog: PBANKA_0912300)

  • Relative Growth Rate: 0.97 ± 0.10
  • Confidence: 5.92

RMgmDB ABS Phenotype: Different from wild type (Pb ortholog: PBANKA_0912300)

Modification: Disrupted | RMgm-2537

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: Q8II01

"Best" AlphaFill ligand hit: No AlphaFill hits

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
3.1.31.1 micrococcal nuclease SDSEDTAcaspase-3Mononucleotidesoligonucleotidesmetacaspase mcII-Paadenosine 3',5'-diphosphatethymidine 3',5'-bisphosphate3',5'-deoxythymidine diphosphatedeoxythymidine 3',5'-diphosphatedeoxythymidine 3',5'-bisphosphate2'-deoxythymidine 3',5'-diphosphate

No evidence of orthology to BindingDB entries

Orthology Information

Ortholog Group (OrthoMCL): OG6_102097

Most Similar Human Ortholog: Q7KZF4

TM-align score: 0.62 | RMSD: 5.38

Seq Identity: 0.23 | Length: 689 / 1098

All Human Orthologs (OrthoMCL):

Gene ID Description
ENSG00000197157 staphylococcal nuclease and tudor domain containing 1

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 13 74 44 69
disruptive 19 110 76 179
missense 15 96 71 153

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 26 146 56 76
disruptive 48 271 172 337
missense 30 223 139 212

PlasmoDB Total SNPs: 301

Non-coding: 182 | Synonymous: 76 | Nonsynonymous: 43 | Stop Codon: 0

Protein Information

Protein Length: 1098 | Molecular Weight (kDa): 128.546

UniProt ID(s): Q8II01

PDB ID(s): None

Isoelectric Point: 8.9

Protein Domain Annotations:

Source Family ID Description
InterPro IPR002999 Tudor domain
InterPro IPR016071 Staphylococcal nuclease (SNase-like), OB-fold
PFam PF00565 Staphylococcal nuclease (SNase-like), OB-fold
PFam PF00567 Tudor domain
Superfamily SSF50199 N/A
Superfamily SSF63748

Associated Publications

PMID Title Authors DOI/Link
12368864 Genome sequence of the human malaria parasite Plasmodium falciparum. Gardner MJ, Hall N, ..., Barrell B 10.1038/nature01097
16267556 A protein interaction network of the malaria parasite Plasmodium falciparum. LaCount DJ, Vignali M, ..., Hughes RE 10.1038/nature04104
18035357 Tudor domain proteins in protozoan parasites and characterization of Plasmodiumfalciparum tudor staphylococcal nuclease. Hossain MJ, Korde R, ..., Malhotra P 10.1016/j.ijpara.2007.09.018
20713134 Plasmodium falciparum Tudor Staphylococcal Nuclease interacting proteins suggestits role in nuclear as well as splicing processes. Hossain MJ, Korde R, ..., Malhotra P 10.1016/j.gene.2010.08.004
23181666 Organellar proteomics reveals hundreds of novel nuclear proteins in the malariaparasite Plasmodium falciparum. Oehring SC, Woodcroft BJ, ..., Voss TS 10.1186/gb-2012-13-11-r108
30379851 Identification of Plasmodium falciparum nuclear proteins by mass spectrometry andproposed protein annotation. Briquet S, Ourimi A, ..., Vaquero C 10.1371/journal.pone.0205596